, Tracking Stock Market Picks
Enter Symbol:
Intermune, Inc. (ITMN) [hlAlert]

up 105.44 %

Intermune, Inc. (ITMN) rated Buy with price target $50 by Brean Murray

Posted on: Wednesday,  Jul 13, 2011  8:25 AM ET by Brean Murray

Brean Murray rated Buy Intermune, Inc. (NASDAQ: ITMN) on 07/13/2011, when the stock price was $35.97. Since
then, Intermune, Inc. has gained 105.45% as of 09/26/2014's recent price of $73.90.
If you would have followed this Brean Murray's recommendation on ITMN, you would have gained 105.44% of your investment in 1171 days.

InterMune Pharmaceuticals Inc. develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders. The company markets ACTIMMUNE for chronic granulomatous disease and osteopetrosis. The company has active development programs underway for the other disease areas, several of which are in mid-or advanced-stage human testing, known as clinical trials.

Our equity research department is focused on fundamental analysis across the universe of over 200 small/mid cap stocks in our five target sectors. We are committed to providing proprietary action-oriented research to our institutional clients. Small cap growth focus. Our primary area of concentration is growth stocks with market capitalization of $200 million to $5 billion. Global perspective. We are covering U.S. listed stocks for companies domiciled in the U.S., China, Europe and Latin America, with our biggest concentration in the US and China. We were one of the first banks to aggressively expand our research to China and we believe we created one of the premier research franchises in small cap, U.S. listed Chinese companies to complement our strong domestic coverage. Disciplined stock selection. Our research analysts are focused on performing extensive bottoms up due diligence on companies under our coverage by leveraging their industry and management contacts. By combining our bottoms up work with our sector views we seek to generate a consistent flow of high conviction ideas for our clients. Diversified coverage. Our areas of expertise include technology, consumer, healthcare, resources and China small cap. We provide our clients with company-specific as well as sector-specific research across our target sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/13/2011 8:25 AM Buy
35.97 50.00
as of 12/30/2011
1 Week up  8.15 %
1 Month down  -30.61 %
3 Months down  -37.62 %
1 YTD down  -64.97 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy